John T Mullen

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series
    John T Mullen
    Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA
    Ann Surg Oncol 19:4028-35. 2012
  2. doi request reprint Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas
    John T Mullen
    Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
    Cancer 118:3758-65. 2012
  3. doi request reprint Carcinoid tumors of the appendix: a population-based study
    John T Mullen
    Division of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Surg Oncol 104:41-4. 2011
  4. pmc Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study
    Nicole J Look Hong
    Department of Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
    Eur J Cancer 49:875-83. 2013
  5. doi request reprint Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients
    Benjamin Schmidt
    Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:3512-8. 2013
  6. pmc Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy
    John T Mullen
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts
    Cancer 120:3676-82. 2014
  7. doi request reprint Predictors of Lymph Node Metastasis in Western Early Gastric Cancer
    Rima Ahmad
    Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Yawkey 7B, Boston, MA, 02114, USA
    J Gastrointest Surg 20:531-8. 2016
  8. doi request reprint Adjuvant Therapy Completion Rates in Patients with Gastric Cancer Undergoing Perioperative Chemotherapy Versus a Surgery-First Approach
    Eva Fuentes
    Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Yawkey 7B, Boston, MA, 02114, USA
    J Gastrointest Surg 20:172-9. 2016
  9. pmc Prognostic factors and outcomes of patients with myxofibrosarcoma
    Nicole J Look Hong
    Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:80-6. 2013
  10. doi request reprint D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging
    Benjamin Schmidt
    Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:2991-9. 2013

Collaborators

Detail Information

Publications15

  1. doi request reprint Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series
    John T Mullen
    Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA
    Ann Surg Oncol 19:4028-35. 2012
    ..Desmoid tumors are rare and exhibit a highly unpredictable natural history. We sought to analyze prognostic factors associated with recurrence in a large single-institution study of patients with desmoid tumors...
  2. doi request reprint Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas
    John T Mullen
    Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
    Cancer 118:3758-65. 2012
    ..We report the long-term follow-up data on 48 patients treated with this regimen compared to an historical matched-control patient population...
  3. doi request reprint Carcinoid tumors of the appendix: a population-based study
    John T Mullen
    Division of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Surg Oncol 104:41-4. 2011
    ..Carcinoid tumors of the appendix are rare, and as such there are few data guiding their optimal treatment...
  4. pmc Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study
    Nicole J Look Hong
    Department of Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
    Eur J Cancer 49:875-83. 2013
    ..The goal of this study is to assess outcomes in a recent cohort of patients treated on this regimen...
  5. doi request reprint Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients
    Benjamin Schmidt
    Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:3512-8. 2013
    ..The benefit of surgical resection in patients with incurable gastric adenocarcinoma is controversial...
  6. pmc Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy
    John T Mullen
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts
    Cancer 120:3676-82. 2014
    ..In the current study, the authors sought to determine the prognostic significance of treatment-induced pathologic necrosis in patients receiving neoadjuvant chemoradiotherapy for STS...
  7. doi request reprint Predictors of Lymph Node Metastasis in Western Early Gastric Cancer
    Rima Ahmad
    Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Yawkey 7B, Boston, MA, 02114, USA
    J Gastrointest Surg 20:531-8. 2016
    ..We sought to determine the incidence and predictors of LN metastasis in a contemporary cohort of Western patients with early gastric cancer...
  8. doi request reprint Adjuvant Therapy Completion Rates in Patients with Gastric Cancer Undergoing Perioperative Chemotherapy Versus a Surgery-First Approach
    Eva Fuentes
    Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Yawkey 7B, Boston, MA, 02114, USA
    J Gastrointest Surg 20:172-9. 2016
    ..A significantly higher percentage of gastric cancer patients treated with perioperative chemotherapy receive some or all of the recommended components of multimodality therapy than patients treated with a surgery-first approach. ..
  9. pmc Prognostic factors and outcomes of patients with myxofibrosarcoma
    Nicole J Look Hong
    Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:80-6. 2013
    ..The objectives of this study were to analyze the prognostic factors and outcomes of patients with MFS treated at a single institution...
  10. doi request reprint D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging
    Benjamin Schmidt
    Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:2991-9. 2013
    ....
  11. pmc Familial Gastric Cancers
    Namrata Setia
    Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA
    Oncologist 20:1365-77. 2015
    ..This article reviews the molecular genetics, clinical and pathologic features, surveillance guidelines, and preventive measures of common and less common hereditary gastric cancer predisposition syndromes...
  12. pmc Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Theodore S Hong
    Theodore S Hong, Jennifer Y Wo, Beow Y Yeap, Erin I McDonnell, Lawrence S Blaszkowsky, Eunice L Kwak, Jill N Allen, Jeffrey W Clark, Lipika Goyal, Janet E Murphy, John A Wolfgang, Lorraine C Drapek, Ronald S Arellano, John T Mullen, Sam S Yoon, Kenneth K Tanabe, Cristina R Ferrone, David P Ryan, Thomas F DeLaney, and Andrew X Zhu, Massachusetts General Hospital, Harvard Medical School Harvey J Mamon, Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA Edgar Ben Josef, University of Pennsylvania Hospital, Philadelphia, PA and Milind M Javle and Christopher H Crane, University of Texas MD Anderson Cancer Center, Houston, TX
    J Clin Oncol 34:460-8. 2016
    ..To evaluate the efficacy and safety of high-dose, hypofractionated proton beam therapy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC)...
  13. doi request reprint Factors influencing readmission after curative gastrectomy for gastric cancer
    Rima Ahmad
    Department of Surgery, Massachusetts General Hospital, Boston, MA
    J Am Coll Surg 218:1215-22. 2014
    ..We sought to determine the 30-day readmission rate as well as the potential risk factors for readmission at our institution in patients undergoing gastrectomy for gastric cancer with curative intent...
  14. doi request reprint Post-operative renal function following nephrectomy as part of en bloc resection of retroperitoneal sarcoma (RPS)
    Melissa A Hull
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts
    J Surg Oncol 112:98-102. 2015
    ..Although resection of RPS with en bloc nephrectomy confers the potential benefit of improved locoregional tumor control, little has been published about the long-term post-operative renal function of these patients...
  15. pmc Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists
    Elizabeth H Baldini
    Department of Radiation Oncology, Brigham and Women s Hospital L2, Dana Farber Brigham and Women s Cancer Center, Boston, MA, USA
    Ann Surg Oncol 22:2846-52. 2015
    ..We sought to evaluate variability in HR GTV boost target volume delineation among collaborating sarcoma radiation and surgical oncologist teams...